Table 1 Baseline characteristics of 12 severely immunosuppressed AIDS patients enrolled in AAIT

From: HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients

Patient

Gender

Age (years)

Transmission

route

Laboratory examinations

Viral nucleic acid

ART relative to initiation of AAIT (days)

Times of

transfusion

Dose of each transfusion

108/kg

HIV RNA

(copies/ml)

CD4

(cells/μl)

CD8

(cells/μl)

WBC

(109/L)

RBC (1012/L)

PLT

(109/L)

HGB

(g/L)

ALT

(U/L)

AST

(U/L)

Cre

(μmol/L)

CMV

(IU/ml)

EBV

(IU/ml)

HBV

(copies/ml)

HCV

(copies/ml)

01-W

M

36

Heterosexual

<20

33

602

5.43

3.37

352

105

9

18

81

<100

2.58E+02

<40

<50

−104

5

3/2.5/2.5/

2.5/2.5

02-Z

M

28

Heterosexual

2.17E+04

7

227

1.31

2.59

136

78

20

42

53

<100

1.97E+02

<40

<50

−28

4

3/3.1/3/3

03-G

M

18

Homosexual

2.32E+06

9

688

3.15

4.18

131

121

58

35

74

<100

<100

<40

<50

−5

3

3/3.5/2.6

04-D

M

35

Homosexual

1.62E+02

1

40

1.75

3.05

170

87

18

24

63

4.17E+02

<100

<40

<50

−58

3

2.6/2.9/2.9

05-Z

M

29

Homosexual

8.88E+05

32

778

1.88

4.41

142

127

95

68

88

<100

<100

<40

<50

+20

3

3/2.6/2.6

06-L

M

44

Homosexual

1.01E+06

11

90

6.25

4.38

394

128

40

38

62

1.74E+04

6.64E+02

<40

<50

−10

2

3/2.5

07-X

M

34

Unknown

1.76E+07

4

590

3.16

4.44

239

127

29

46

84

<100

<100

<40

<50

−6

3

3.5/3/3

08-D

M

54

Homosexual

2.20E+05

10

268

7.09

4.66

325

151

33

18

85

<100

<100

<40

<50

+8

2

3/3

09-L

F

31

Heterosexual

1.25E+07

13

474

4.27

3.96

87

127

94

98

47

1.27E+03

<100

<40

<50

+2

3

3.3/3.2/3.2

10-L

M

35

Heterosexual

4.47E+05

20

374

4.32

3.76

278

121

47

27

74

<100

<100

<40

<50

+7

2

3.5/2.6

11-S

M

39

Unknown

2.53E+05

7

258

2.29

5.83

281

165

59

39

69

<100

<100

<40

<50

−3

2

3.1/3

12-L

M

27

Homosexual

8.86E+04

15

459

2.87

4.63

106

133

112

32

72

3.04E+04

<100

<40

<50

+2

2

3.3/3

  1. “−” means ART before AAIT treatment, “+” means ART after AAIT treatment
  2. M male, F female, WBC white blood cell, RBC red blood cell, PLT platelet, HGB hemoglobin, ALT alanine aminotransferase, AST glutamic oxaloacetic transaminase, Cre creatinine, CMV cytomegalovirus, EBV Epstein–Barr virus, HBV hepatitis B virus, HCV hepatitis C virus